Become a member

Cart (0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Tokyo Big Sight

Nov 16, 2014 9:00 AM - Nov 18, 2014 6:30 PM

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

11th Annual Meeting DIA Japan 2014

Back to Agenda

[V5-S3] Brain Storming How We Can Conduct Clinical Trials - A Company-Funded Company-Lead Trial is Not Only the Way to Run a Clinical Trial

Session Chair(s)

Tomoko Hirohashi, PhD

Director, Clinical Research Oncology

Pfizer Japan Inc., Japan

Brain Storming How We Can Concudt Clinical Trials? A Company-Funded Company-Lead Trials is Not Only the Way to Run a Clinical Trial? - Introduction

Speaker(s)

Brain Storming How We Can Concudt Clinical Trials? A Company-Funded Company-Lead Trials is Not Only the Way to Run a Clinical Trial? - Introduction

Tomoko Hirohashi, PhD

Pfizer Japan Inc., Japan

Director, Clinical Research Oncology

Clinical Development Strategy Including Company-Initiated Clinical Study

Tomio Nakamura

Eisai Co., Ltd., Japan

Senior Director, Japan/Asia Clinical Development Oncology Group

Drug development based on the collaboration between Academia and the companies- Proposal and requests from Academia-

Koichi Goto, MD, PhD

Daiichi Sankyo Company, Limited, Japan

Scientist, Medicinal Research Laboratories

Experience of Collaboration with External Partners - The Case of Non-Domestic Company -

Akihira Mukaiyama, MSc

GlaxoSmithKline K.K., Japan

Manager, Medicines Development, Development & Medical Afffairs Division

Have an account?